KHIDI Regenerative Medicine R&D
Funds organizations through KHIDI Regenerative Medicine Innovation, helping them support cell, gene, and tissue engineering.
KHIDI invests in regenerative medicine as one of its three priority next-generation technology areas alongside innovative new drugs and medical devices. R&D support covers cell therapy, gene therapy, and tissue engineering, with KHIDI providing planning, evaluation, and management of MOHW-funded projects in this area. The program is run within the broader Healthcare R&D Support pillar and may share cycle calendar with the umbrella Health Industry R&D Promotion calls.
Biotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.